Teleallergy: Where Have We Been and Where Are We Going?
Telemedicine uptake in allergy/immunology was slow before the coronavirus disease 2019 pandemic, but has accelerated since. This review examines where telemedicine has been in allergy/immunology and where it is headed in the future. Focus is placed on patient, physician, and health care professional satisfaction with telemedicine, capacity to expand access to allergy/immunology care, cost considerations, the regulatory environment, and future applications of telemedicine including adherence monitoring, wearable biosensors, artificial intelligence, and machine learning addressed.
J Allergy Clin Immunol Pract
Humans; COVID-19; Artificial Intelligence; Telemedicine; Physicians; Hypersensitivity; Patient Satisfaction
Access; Adherence monitoring; Healthcare provider satisfaction; Patient satisfaction; Teleallergy; Telehealth; Telemedicine
Ramsey A, Wu AC, Bender BG, Portnoy J. Teleallergy: Where Have We Been and Where Are We Going?. J Allergy Clin Immunol Pract. 2023;11(1):126-131. doi:10.1016/j.jaip.2022.08.032